Critical Outcome Technologies, Inc. (OTCMKTS:COTQF – Get Free Report) crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.00 and traded as high as $0.0001. Critical Outcome Technologies shares last traded at $0.00, with a volume of 0 shares traded.
Critical Outcome Technologies Stock Down 100.0%
About Critical Outcome Technologies
Critical Outcome Technologies Inc is a clinical-stage biotechnology company that integrates artificial intelligence and machine learning into its drug discovery and development processes. The company’s proprietary platform enables rapid in silico screening, lead optimization and preclinical validation of small-molecule candidates, with a primary focus on oncology and infectious diseases.
Using its AI-enabled discovery engine, Critical Outcome Technologies has generated a pipeline of novel therapeutic candidates designed to address high-unmet-need targets.
See Also
- Five stocks we like better than Critical Outcome Technologies
- Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
- J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
- Wendy’s Rally Fades After Trian Steps Back: Was It Ever Real?
- GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test
Receive News & Ratings for Critical Outcome Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Critical Outcome Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
